Next Article in Journal
Fever after Vaccination against SARS-CoV-2 with mRNA-Based Vaccine Associated with Higher Antibody Levels during 6 Months Follow-Up
Previous Article in Journal
Durability of Humoral Responses after the Second Dose of mRNA BNT162b2 Vaccine in Residents of a Long Term Care Facility
 
 
Brief Report
Peer-Review Record

SARS-CoV-2 T-Cell Responses in Allogeneic Hematopoietic Stem Cell Recipients following Two Doses of BNT162b2 mRNA Vaccine

Vaccines 2022, 10(3), 448; https://doi.org/10.3390/vaccines10030448
by Béatrice Clémenceau 1,*, Thierry Guillaume 1,2, Marianne Coste-Burel 3, Pierre Peterlin 2, Alice Garnier 2, Amandine Le Bourgeois 2, Maxime Jullien 2, Jocelyn Ollier 1, Audrey Grain 1, Marie C. Béné 1,4, Henri Vié 1 and Patrice Chevallier 1,2,*
Reviewer 1: Anonymous
Reviewer 2: Anonymous
Vaccines 2022, 10(3), 448; https://doi.org/10.3390/vaccines10030448
Submission received: 27 January 2022 / Revised: 4 March 2022 / Accepted: 9 March 2022 / Published: 14 March 2022

Round 1

Reviewer 1 Report

Authors reported the simple statistic analysis data regarding to more than 100 Aollo-HSCT patients whose T cell responses after two shots of BNT mRNA vaccine. Overall, it is a good report, although it is not a novelty, it is really one of the pioneer studies. The weak antibody immuno-response tis known in Allo-HSCT recipients, and the role of T cell role of the immune system is brought into sharper focus. T cells might be overlooked in the fight against COVID-19. This report may provide an interested and useful information. As if authors can provide more discussions among the 4 similar reports, including authors’ report, that should improve the importance of this manuscript. For a brief report point of view, I only have two more minor comments:

  1. Authors should carefully check whether there are more typing errors in the text including figure legends, such as: 1). Page 5 line 155 and line 157, the “(a)” and “(b)” should be corrected as “(A)” and “(B)”, respectively, to appropriately correlate figure label with its relative legend. 2). Page 7 line 188, …. (data not shown). “(D)” Bar graphs showing…. That should be a typing error and to be corrected as “(C)”.
  2. For figure 1 & 2, the small font size and its low resolution that make not clearly enough labelling for the graphs.

Author Response

Reviewer 1: 

Authors reported the simple statistic analysis data regarding to more than 100 Aollo-HSCT patients whose T cell responses after two shots of BNT mRNA vaccine. Overall, it is a good report, although it is not a novelty, it is really one of the pioneer studies. The weak antibody immuno-response tis known in Allo-HSCT recipients, and the role of T cell role of the immune system is brought into sharper focus. T cells might be overlooked in the fight against COVID-19. This report may provide an interested and useful information. As if authors can provide more discussions among the 4 similar reports, including authors’ report that should improve the importance of this manuscript.

 

We have now discussed the specific T-cell responses in terms of CD4/CD8 + T cells responses comparing our results with those published. We have also provided a paragraph regarding predictive factors of the humoral and cellular responses.

 

 

For a brief report point of view, I only have two more minor comments:

  1. Authors should carefully check whether there are more typing errors in the text including figure legends, such as: 1). Page 5 line 155 and line 157, the “(a)” and “(b)” should be corrected as “(A)” and “(B)”, respectively, to appropriately correlate figure label with its relative legend. 2). Page 7 line 188, …. (data not shown). “(D)” Bar graphs showing…. That should be a typing error and to be corrected as “(C)”.

 

Changes have been made accordingly.

 

  1. For figure 1 & 2, the small font size and its low resolution that make not clearly enough labelling for the graphs.​

Figures are now provided in the .jpg format showing adequate resolution.

Author Response File: Author Response.doc

Reviewer 2 Report

This is a well performed and well written study on the occurrence and function of SARS-Cov-2 spike protein-specific CD4 T cells after vaccination in patients with hematopoietic stem cell transplantation. The study is of high interest in general and for patients with HSCT.

Concerns

-Graphic quality of figures is poor and has to be improved.

Author Response

Reviewer 2: This is a well performed and well written study on the occurrence and function of SARS-Cov-2 spike protein-specific CD4 T cells after vaccination in patients with hematopoietic stem cell transplantation. The study is of high interest in general and for patients with HSCT.

Concerns

-Graphic quality of figures is poor and has to be improved.

 

Figures are now provided in the .jpg format showing adequate resolution.

Author Response File: Author Response.doc

Back to TopTop